Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer

Journal of International Medical Research

Volumn 40, Issue 2, 2012, Pages 681-686

  Dong, R ^a   Yu, J ^a   Pu, H ^a   Zhang, Z ^a   Xu, X ^a  

^a Soochow University   (China)

Author keywords

Early diagnosis; Gene promoter; Hypermethylation; Ovarian cancer; SLIT homologue 2 (SLIT2); Tumour suppressor gene

Indexed keywords

CA 125 ANTIGEN; GENOMIC DNA;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; EARLY DIAGNOSIS; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARY CANCER; POLYMERASE CHAIN REACTION; PROMOTER REGION; SLIT HOMOLOGUE 2 GENE; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

EID: 84860454489     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000231     Document Type: Article

References (25)

1. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Shen K: Problems in connection to treatment of ovarian tumours and fertility preservation. Zhonghua Fu Chan Ke Za Zhi 2003; 38: 489-492 [in Chinese].
3. Yu J, Cao Q, Yu J, et al: The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene 2010; 29: 5370-5380.
4. Marlow R, Strickland P, Lee JS, et al: SLITs suppress tumour growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res 2008; 68: 7819-7827.
5. Tseng RC, Lee SH, Hsu HS, et al: SLIT2 attenuation during lung cancer progression deregulates β-catenin and E-cadherin and associates with poor prognosis. Cancer Res 2010; 70: 543-551.
6. Yiin JJ, Hu B, Jarzynka MJ, et al: Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol 2009; 11: 779-789.
7. Xu Y, Li WL, Fu L, et al: Slit2/Robo1 signaling in glioma migration and invasion. Neurosci Bull 2010; 26: 474-478.
8. Georgas K, Burridge L, Smith K, et al: Assignment of the human slit homologue SLIT2 to human chromosome band 4p15.2. Cytogenet Cell Genet 1999; 86: 246-247.
9. Dallol A, Morton D, Maher ER, et al: SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 2003; 63: 1054-1058.
10. Jin J, You H, Yu B, et al: Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Biochem Biophys Res Commun 2009; 379: 86-91.
11. Singh RK, Indra D, Mitra S, et al: Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumour suppressor gene. Hum Genet 2007; 122: 71-81.
12. Dallol A, Da Silva NF, Viacava P, et al: SLIT2, a human homologue of the Drosophila Slit2 gene, has tumour suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 2002; 62: 5874-5880.
13. Ellinger J, Albers P, Perabo FG, et al: CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J Urol 2009; 182: 324-329.
14. Yang HJ, Liu VW, Wang Y, et al: Detection of hypermethylated genes in tumour and plasma of cervical cancer patients. Gynecol Oncol 2004; 93: 435-440.
15. Müller HM, Fiegl H, Widschwendter A, et al: Prognostic DNA methylation marker in serum of cancer patients. Ann N Y Acad Sci 2004; 1022: 44-49.
16. Herman JG, Graff JR, Myöhänen S, et al: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
17. Jones PA: DNA methylation and cancer. Oncogene 2002; 21: 5358-5360.
18. Morris MR, Hesson LB, Wagner KJ, et al: Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma. Oncogene 2003; 22: 6794-6801.
19. Lal G, Padmanabha L, Provenzano M, et al: Regulation of 14-3-3 expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation. Cancer Lett 2008; 267: 165-174.
20. Zhang Q, Ying J, Zhang K, et al: Aberrant methylation of the 8p22 tumour suppressor gene DLC1 in renal cell carcinoma. Cancer Lett 2007; 249: 220-226.
21. Mittag F, Kuester D, Vieth M, et al: DAPK promotor methylation is an early event in colorectal carcinogenesis. Cancer Lett 2006; 240: 69-75.
22. Ibanez de Caceres I, Battagli C, Esteller M, et al: Tumour cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res 2004; 64: 6476-6481.
23. Usadel H, Brabender J, Danenberg KD, et al: Quantitative adenomatous polyposis coli promoter methylation analysis in tumour tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002; 62: 371-375.
24. Kawakami K, Brabender J, Lord RV, et al: Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 2000; 92: 1805-1811.
25. Qiu H, Zhu J, Yu J, et al: SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activated. Asian Pac J Cancer Prev 2011; 12: 791-795.